Juvenile Myasthenia Gravis (JMG) is a rare disorder, defined as myasthenia gravis in
children younger than 18 years of age. While clinical phenotypes are similar to adults, there …

Myasthenia gravis is a disorder of neuromuscular transmission that leads to fatigue of
skeletal muscles and fluctuating weakness. Myasthenia that affects children can be …

Myasthenia gravis (MG) is a rare condition caused by autoantibodies against acetylcholine
receptors on postsynaptic membrane that leads to weakness of skeletal muscles. About 7 of …

The diagnostic and referral workflow for children with neuromuscular disorders is evolving,
particularly as newborn screening programs are expanding in tandem with novel therapeutic …

Thymectomy is an established treatment in adult myasthenia gravis, but its exact role in
juvenile myasthenia gravis (JMG) is still uncertain. Thymectomy is frequently considered in …

Introduction: Myasthenia gravis (MG) is one of the best treatable autoimmune diseases.
However, in most patients, treatment is necessarily long-term and related side effects are a …

Background Juvenile myasthenia gravis (JMG) is a rare autoimmune disease that has so far
only been described in small cohort studies. We defined the clinical characteristics …

Background Thymectomy is a treatment for pediatric myasthenia gravis, but the efficacy over
time is unknown. Multi-institutional data are also lacking. Therefore, the objective of this …

Thymectomy in myasthenia gravis : Current Opinion in Neurology Thymectomy in myasthenia
gravis : Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get …

With the exception of thymectomy, immune modulatory treatment strategies and clinical trials
in myasthenia gravis over the past 50 y were mainly borrowed from experience in other …